Immunogenic Epitopes Mapping of BB0108 and BB0323 Proteins from Borrelia burgdorferi Sensu Lato in the Context of Lyme Disease Diagnosis
Year: 2026
Type: article
Abstract: Lyme borreliosis (LB) is an emerging tick-borne zoonosis in Europe, transmitted primarily by Ixodes ricinus and Ixodes persulcatus. The causative agent, Borrelia burgdorferi sensu lato (s.l.), comprises approximately 20 genospecies, of which five are responsible for human infection in Europe: Borrelia afzelii, Borrelia garinii, B. burgdorferi sensu stricto (s.s.), Borrelia bavariensis, and Borrelia spielmanii. Due to limitations in direct pathogen detection, LB diagnosis relies mainly on serological assays. However, cross-reactive antibodies can compromise both specificity and sensitivity, highlighting the need for more specific antigenic targets and improved diagnostic strategies beyond conventional two-tier approaches. Epitope mapping represents a promising strategy to identify highly specific immunoreactive regions and reduce cross-reactivity. In this study, we identified immunoreactive peptides to improve LB serodiagnosis. Linear B-cell epitopes were mapped using peptide microarrays across three major European genospecies (B. afzelii, B. burgdorferi s.s., and B. garinii), revealing regions reactive to IgG, IgM, or both. Selected IgG peptides showed sensitivities of 81.6–92.1% and specificities of 92.1–94.7%, whereas IgM peptides exhibited sensitivities of 77.8–94.4% and specificities of 94.6–97.3%. A chimeric protein designed for IgG detection achieved a sensitivity of 94.7% and a specificity of 97.4%. These findings demonstrate that epitope-based antigen design and chimeric constructs can enhance the accuracy of LB serodiagnosis.
Source: ACS Infectious Diseases
Language: English
Subfield: Parasitology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7234091551
